pd 173074 has been researched along with Craniofacial Dysarthrosis in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Crouzon syndrome is caused by mutations in fibroblast growth factor receptor 2 (FGFR2) leading to constitutive activation of receptors in the absence of ligand binding." | 1.33 | A model for the pharmacological treatment of crouzon syndrome. ( Darvann, T; Morriss-Kay, G; Ornitz, DM; Perlyn, CA; Tenenbaum, M, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Perlyn, CA | 1 |
| Morriss-Kay, G | 1 |
| Darvann, T | 1 |
| Tenenbaum, M | 1 |
| Ornitz, DM | 1 |
1 other study available for pd 173074 and Craniofacial Dysarthrosis
| Article | Year |
|---|---|
A model for the pharmacological treatment of crouzon syndrome.
Topics: Animals; Cranial Sutures; Craniofacial Dysostosis; Cysteine; Disease Models, Animal; Mice; Mice, Mut | 2006 |